Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Free heme, specifically ferriprotoporphyrin IX (FP-IX), is a toxic byproduct generated during the intraerythrocytic stage of the Plasmodium falciparum life cycle (Sullivan et al., 1996). The parasite digests host hemoglobin within its acidic digestive vacuole to obtain essential amino acids, releasing large quantities of free heme. Because free heme is redox-active and can damage parasite membranes and proteins, the parasite detoxifies it by sequestering it into an insoluble crystalline form called hemozoin, or malaria pigment (Egan, 2008). Many antimalarial drugs, most notably the quinolines like chloroquine, act by binding to free heme or the growing faces of hemozoin crystals, thereby preventing further crystallization (Combrinck et al., 2013). This leads to the accumulation of toxic free heme within the digestive vacuole, ultimately causing parasite death through oxidative stress and membrane disruption. This pathway remains a cornerstone of antimalarial therapy, although resistance mechanisms such as mutations in the PfCRT transporter pose significant therapeutic challenges (Haldar et al., 2018).
Inhibition of heme biocrystallization into hemozoin, leading to the accumulation of toxic free heme which causes oxidative damage and membrane lysis within the parasite digestive vacuole.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferriprotoporphyrin IX (Free heme) (FP-IX).